Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
They are very helpful and responsive to questions
The SURMOUNT-1 trial recorded 22.5% average weight loss at this dose, roughly 52 pounds
Tirzepatide is injected subcutaneously into the abdomen, the upper outer thigh, or the back of the upper arm
doi:10.1507/endocrj.EJ240286 Ou, Y., Cui, Z., Lou, S., Zhu, C., Chen, J., Zhou, L., Zou, F
About 30 to 40 percent of first-dose users report noticeable appetite reduction within the first week
Side Effects Semaglutide: Common Side Effects: Nausea Vomiting Diarrhoea Constipation Abdominal pain Less Common Side Effects: Headache Fatigue Dizziness Hypoglycaemia (especially in individuals with type 2 diabetes) Pancreatitis (rare but serious) Tirzepatide: Common Side Effects: Nausea Vomiting Diarrhea Constipation Abdominal pain Less Common Side Effects: Decreased appetite Dyspepsia (indigestion) Injection site reactions Hypoglycemia (more common when combined with insulin or sulfonylureas) Pancreatitis (rare but serious) Administration Semaglutide: Administered via injection
